Skip to main content
Clinical Trials/NCT01681394
NCT01681394
Completed
Not Applicable

Effect of the Administration of a Polyphenol-rich Cocoa Extract on Peripheral Blood Mononuclear Cells Gene Expression in Humans

Technological Centre of Nutrition and Health, Spain1 site in 1 country25 target enrollmentJune 2012

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cardiovascular Function
Sponsor
Technological Centre of Nutrition and Health, Spain
Enrollment
25
Locations
1
Primary Endpoint
Gene expression changes in PBMCs (using a microarray)
Status
Completed
Last Updated
12 years ago

Overview

Brief Summary

It has been evidenced that chocolate and cocoa consumption increase vasodilation and reduce blood pressure. However, the mechanisms implicated in these effects have not been elucidated yet. The purpose of this study is to evaluate changes in gene expression induced by the administration of a polyphenol-rich cocoa extract in peripheral blood mononuclear cells (PBMC) in humans.

Detailed Description

This is a prospective, randomized, controlled, double-blind and cross-over study. The intervention will consist in the administration of 250g of chocolate cream with or without the extract after 12 hours fasting. Blood samples will be taken at point 0, 2, 3 and 6 hours after the administration. At each time point, blood pressure and endothelial function (with a non-invasive method) will be measured.

Registry
clinicaltrials.gov
Start Date
June 2012
End Date
February 2013
Last Updated
12 years ago
Study Type
Interventional
Study Design
Crossover
Sex
Male

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1.Healthy males between the ages of 20 and 39 who do not meet any of the exclusion criteria.

Exclusion Criteria

  • Body mass index (BMI) lower than 18 or greater than 27 Kg/m2
  • Regular medication
  • Consumption of medication during the last week
  • Following a weight-loss diet
  • Vegetarians
  • Abnormal glucose levels
  • Cardiovascular disease
  • Gastrointestinal disease

Outcomes

Primary Outcomes

Gene expression changes in PBMCs (using a microarray)

Time Frame: 0-6 hours

Secondary Outcomes

  • Blood pressure(0-2-3-6 hours)
  • Endothelial function (assessed by ischemic reactive hyperemia)(0-2-3-6 hours)
  • Plasma levels of procyanidins metabolites(0-6 hours)

Study Sites (1)

Loading locations...

Similar Trials